Key points from article :
Investigators calculated ten-year CVD risk probabilities at baseline for the 19,114 ASPREE participants.
In people aged 70 years or over with no known CVD, there is no effect of 100 mg of daily aspirin.
Results of the ASPREE trial were presented at ESC Congress 2019.
New ways to identify an increased CVD risk will be investigated in the ASPREE longitudinal follow-up study.
